Citations

Clear

3314 citation(s) found for "Yu, Alexander".

Whole‐exome sequencing of transforming oral lichen planus reveals mutations in DNA damage repair and apoptosis pathway genes
Xie, Fangyi , Gleue, Casey A. , Deschaine, Maria , Dasari, Surendra , Lau, Julie S., Sartori‐Valinotti, Julio C. , Meves, Alexander , Lehman, Julia S. , Lehman, Julia S

Mayo Clinic

Journal of Oral Pathology & Medicine | February 11, 2022 | Volume: 51 | Issue: 4 | Pages: 395-404

10.1111/jop.13284 | PMID 35146808 Get It

AbstractBackgroundOral lichen planus confers a 1% risk of transformation to oral squamous cell carcinoma. While prior exome sequencing studies have identified multiple genetic mutations in oral squamous cell carcinoma, mutational analyses of lichen planus‐derived OSCC are lacking. We sought to clarify genomic events associated with oral lichen planus transformation.MethodsUsing rigorous diagnostic criteria, we retrospectively identified patients with non‐transforming oral lichen planus (i.e., known to be non‐transforming with 5 years of clinical follow‐up; n = 17), transforming oral lichen planus (tissue marginal to oral squamous cell carcinoma, n = 9), or oral squamous cell carcinoma arising in lichen planus (n = 17). Gene mutational profiles derived from whole‐exome sequencing on fixed mucosal specimens were compared among the groups.ResultsThe four most frequently mutated genes in transforming oral lichen planus and oral squamous cell carcinoma (TP53, CELSR1, CASP8, and KMT2D) identified 12/17 (71%) of oral squamous cell carcinomas and 5/9 (56%) of transforming oral lichen planus but were absent in non‐transforming oral lichen planus. We identified other known oral squamous cell carcinoma mutations (TRRAP, OBSCN, and LRP2) but also previously unreported mutations (TENM3 and ASH1L) in lichen planus‐associated oral squamous cell carcinomas.ConclusionsThese findings suggest alterations in DNA damage response and apoptosis pathways underlie lichen planus‐related oral squamous cell carcinoma transformation and are supported by mutational signatures indicative of DNA damage. This study characterized patterns of mutational events present in oral lichen planus associated with squamous cell carcinoma and in squamous cell carcinoma associated with oral lichen planus but not in non‐transforming oral lichen planus.
Targeted ablation of gastric pacemaker sites to modulate patterns of bioelectrical slow wave activation and propagation in an anesthetized pig model
Aghababaie, Zahra , Cheng, Leo K. , Paskaranandavadivel, Niranchan , Avci, Recep , Chan, Chih-Hsiang Alexander , Matthee, Ashton , Asirvatham, Samuel J. , Farrugia, Gianrico , O’Grady, Gregory , Angeli, Timothy R. , Farrugia, Gianrico , O'Grady, Gregory , Angeli-Gordon, Timothy R , Asirvatham, Samuel J , Paskaranandavadivel, Niranchan , Amirapu, Satya , Beyder, Arthur

Mayo Clinic

American Journal of Physiology-Gastrointestinal and Liver Physiology | February 9, 2022 | Volume: 322 | Issue: 4 | Pages: G431-G445

10.1152/ajpgi.00332.2021 | PMID 35137624 Get It

This study presents gastric ablation as a novel tool for modulating gastric bioelectrical activation, including eliminating the normal gastric pacemaker site as well as abnormal ectopic pacemaker sites underlying gastric dysrhythmias. Targeted application of radiofrequency ablation was able to eliminate these pacemaker sites without disrupting surrounding conduction capability or tissue structure. Gastric ablation presents a powerful new research tool for modulating gastric electrical activation and may likely hold therapeutic potential for disorders of gastric function.
Does Proximal Hamate Graft for Proximal Scaphoid Reconstruction Restore Native Wrist Kinematics?
Burnier, Marion , Gil, Joseph A. , Hooke, Alexander W. , Elhassan, Bassem T. , Kakar, Sanjeev , Hooke, Alexander, Elhassan, Bassem, Kakar, Sanjeev , Elhassan, Bassem T.

Mayo Clinic

HAND | February 8, 2022 | Volume: 18 | Issue: 5 | Pages: 732-739

10.1177/15589447211063570 | PMID 35130742 Get It

Background: The objective of this study was to determine whether reconstruction of the proximal pole of the scaphoid with a proximal hamate graft restores native carpal kinematics. Methods: A cadaveric study was designed assessing wrist kinematic after proximal hamate graft for proximal pole of the scaphoid nonunion. Wireless sensors were mounted to the carpus using a custom pin and suture anchor system to 8 cadavers. A wrist simulator was used to move the wrist through a cyclical motion about the flexion/extension and radial/ulnar deviation axes. Each specimen was tested under a series of 3 conditions: (1) a native state, “Intact”; (2) fractured scaphoid proximal pole, “Fracture”; and (3) post-reconstruction of the proximal pole of the scaphoid using a proximal hamate graft, “Graft.” Results: The fracture condition resulted in a statistically significant change in scapholunate kinematics across the entire arc of motion relative to the intact condition. Reconstruction with proximal hamate grafts restored scapholunate kinematics close to the intact state in both flexion/extension and radial/ulnar deviation axes. The lunocapitate flexion during wrist flexion was significantly different after the hamate graft reconstruction. Conclusions: Proximal hamate to scaphoid transfer resulted in restoration of near normal carpal kinematics to the intact state.
Abstract WP237: Uric Acid Expressed Within Carotid Atherosclerotic Plaque And Serum Uric Acid Are Associated With Cerebrovascular Events
Nardi, Valentina , Franchi, Federico , Prasad, Megha , Fatica, Erica M. , Alexander, Mariam P., Bois, Melanie C. , Lam, Josephine, Meyer, Fredric B. , Lanzino, Giuseppe, Lerman, Lilach O. , Nardi, Valentina , Lanzino, Giuseppe , Singh, Ravinder , Lerman, Amir

Mayo Clinic

Stroke | February 3, 2022 | Volume: 53 | Issue: Suppl_1 | Pages: No page available

10.1161/str.53.suppl_1.wp237 Get It

Introduction: Uric acid (UA) level within carotid plaque specimens and its association with cerebrovascular events has not been detected or quantified. Systemically, serum uric acid (SUA) is a marker of inflammation and risk factor for atherosclerosis. However, its association with carotid plaque instability and subsequent cerebrovascular events remains unclear. Hypothesis: We hypothesized that UA may play a role in carotid artery atherosclerosis and stroke pathogenesis. In patients undergoing carotid endarterectomy (CEA), we aimed to determine whether UA is present differentially in carotid plaques of symptomatic versus asymptomatic patients and whether SUA is associated with cerebrovascular symptoms before surgery and major adverse cardiovascular events (MACE) in the follow-up to CEA. Methods: We prospectively collected 32 carotid plaques during CEA. We qualitatively assessed the presence of UA by using Gomori methenamine silver (GMS) staining and immunohistochemistry with anti-UA antibodies. We extracted and measured the quantity of UA in carotid plaques by using an enzymatic colorimetric assay. A retrospective analysis of a clinical database of 534 consecutive patients who underwent CEA was performed. We defined as symptomatic those patients with history of stroke, TIA and amaurosis fugax. Results: UA positive staining was detected in higher number of carotid plaques from symptomatic compared to asymptomatic patients on both staining, GMS [20 (86.9%) vs 2 (22.2%); p=0.001] and immunohistochemistry anti-UA [16 (69.5%) vs 1 (11.1%); p=0.004]. Moreover, we found a significantly higher concentration of UA in carotid plaque from symptomatic compared to asymptomatic patients [25.1 (9.5) μg/g vs 17.9 (3.8) μg/g; p=0.021]. SUA level in patients prior to CEA was significantly higher in the symptomatic compared to the asymptomatic group [6.0 (4.8-7.1) mg/dL vs 5.2 (4.4-6.3) mg/dL; p<0.001] and it was significantly higher in patients who developed MACE after CEA versus those that did not [6.0 (4.8-7.1) mg/dL vs 5.4 (4.5-6.6) mg/dL; p=0.021]. Conclusions: UA may provide a mechanistic explanation as systemic biomarker and potential tissue contributor for carotid plaque instability and subsequent cerebrovascular and cardiovascular symptoms.
Abstract 97: Development And Validation Of A Deep Machine Learning Tool For Automated Intraventricular Hemorrhage Segmentation And Volume Measurement Using 3d Convolutional Neural Networks
Wong, Alexander , Baig, Saif , Chen, Zejia , Wong, Alexander, Volders, David , Huynh, Thien

Mayo Clinic

Stroke | February 3, 2022 | Volume: 53 | Issue: Suppl_1 | Pages: No page available

10.1161/str.53.suppl_1.97 Get It

Introduction: Development of new intraventricular hemorrhage (IVH) within 24 hours of presentation or expansion of 1mL or more independently predicts poor outcome. Current methods for IVH volume estimation lack sufficient precision to detect this level of change. The best method of quantification with manual/semi-automated segmentation remain clinically impractical. We aimed to train and validate a convolutional neural network (CNN) to autonomously segment and quantify IVH volume in acute intracerebral hemorrhage (ICH) patients. Methods: Imaging data for training and validation was obtained from 3 international multicenter studies. IVH volumes were assessed using CNN, IVH Score (IVHS), Original Graeb Score (oGS), Modified Graeb Score (mGS), and manual segmentation using ITK-SNAP. Agreement between CNN volume and IVHS estimated volume compared to manual segmentation was assessed using intraclass correlation coefficient (ICC) and Bland-Altman charts. Accuracy of CNN segmentation was compared to manual segmentation with Dice similarity coefficient (DSC). Accuracy of hematoma expansion detection was assessed using receiver operating characteristic curves. Results: A total of 172 patients and 311 CT scans were included. Intra-rater reliability was significantly greater for CNN versus IVHS method (ICC 0.99 [95%CI 0.99 - 1.00] vs 0.76 [95%CI 0.66 - 0.83]). Accuracy of CNN segmentation was satisfactory (DSC 0.76 [95%CI 0.75 - 0.78]). Accuracy of hematoma expansion detection was substantially greater in CNN (AUC 0.91 [95%CI 0.85 - 0.97]) versus IVHS, oGS and mGS. Conclusion: Our results demonstrate that a fully automated CNN algorithm is capable of segmenting IVH volumes on multi-center data with higher intra-rater reliability and satisfactory accuracy over the current methods of IVH volume measurement tools. The algorithm has proven to be capable of detecting hematoma expansion with substantially greater accuracy over existing methods of IVH measurement.
A Deep Learning Approach for Detecting Liver Cirrhosis from Volatolomic Analysis of Exhaled Breath
Wieczorek, Mikolaj A. , Weston, Alexander D. , Ledenko, Matthew F, Thomas, Jonathan N., Carter, Rickey E. , Carter, Rickey E , Ledenko, Matthew , Patel, Tushar

Mayo Clinic

No container title available | February 2, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-1258834/v1 Get It

Abstract IntroductionLiver disease such as cirrhosis is known to cause changes in the composition of volatile organic compounds (VOC) present in patient breath samples. Previous studies have demonstrated the diagnosis of liver cirrhosis from these breath samples, but studies are limited to a handful of discrete, well-characterized compounds.MethodsWe utilized VOC profiles from breath samples from 46 individuals, 35 with cirrhosis and 11 healthy controls. A deep-neural network was optimized to discriminate between healthy controls and individuals with cirrhosis.ResultsA 1D convolutional neural network (CNN) was accurate in predicting which patients had cirrhosis with an AUC of 0.90 (95% CI: 0.75, 0.99). Shapley Additive Explanations characterized the presence of discrete, observable peaks which were implicated in prediction, and the top peaks (based on the average SHAP profiles on the test dataset) were noted.ConclusionCNNs demonstrate the ability to predict the presence of cirrhosis based on a full volatolomics profile of patient breath samples. SHAP values indicate the presence of discrete, detectable peaks in the VOC signal.
Genetic Polymorphisms and Correlation with Treatment-Induced Cardiotoxicity and Prognosis in Patients with Breast Cancer
Peddi, Parvin F., Fasching, Peter A. , Liu, Duan , Quinaux, Emmanuel, Robert, Nicholas J., Valero, Vicente, Falkson, Carla I. , Brufsky, Adam , Cunningham, Julie M. , Weinshilboum, Richard M., Pienkowski, Tadeusz, Eiermann, Wolfgang, Bee, Valerie, Wang, Xiaoyan, Wang, Liewei, Yang, Eric H. , Slamon, Dennis J., Hurvitz, Sara A., Pieńkowski, Tadeusz , Crown, John , Falkson, Carla , Brufsky, Adam M , Cunningham, Julie M , Martin, Miguel , Yang, Eric , Liu, Duan , Peddi, Parvin F., Fasching, Peter A , Quinaux, Emmanuel, Robert, Nicholas J., Valero, Vicente, Weinshilboum, Richard M., Eiermann, Wolfgang, Bee, Valerie, Wang, Xiaoyan, Wang, Liewei, Slamon, Dennis J., Hurvitz, Sara A.

Mayo Clinic

Clinical Cancer Research | February 2, 2022 | Volume: 28 | Issue: 9 | Pages: 1854-1862

10.1158/1078-0432.ccr-21-1762 | PMID 35110416 Get It

Abstract Purpose: Cardiac toxicity is a serious potential complication of HER2-directed therapies and anthracyclines. HER2 codon 655 and SLC28A3 gene polymorphisms have been reported to be associated with cardiac toxicity from anti-HER2 and anthracycline therapy, respectively. Association of the polymorphism at HER2 codon 655 with prognosis has also been reported. Experimental Design: Whole blood samples from patients treated on a randomized adjuvant breast cancer trial (BCIRG-006) that compared chemotherapy with or without trastuzumab plus either anthracycline or nonanthracycline chemotherapy were tested for genetic polymorphisms in HER2 codon 655 and SLC28A3. Genotypes were correlated with cardiac function and disease-free survival (DFS) outcomes. Results: Of 3,222 patients enrolled in BCIRG-006, 662 patient samples were successfully genotyped for the rs1136201 allele in HER2 (codon 655): 424 (64%) were AA, 30 (4.5%) were GG, and 208 (31%) were AG genotype. In addition, 665 patient samples were successfully genotyped for the rs7853758 allele in the SLC28A3 gene: 19 (3%) were AA, 475 (71%) were GG, and 171 (26%) were AG genotype. Follow-up time was 10 years. No correlation between DFS, cardiac event rate, or mean left ventricular ejection fraction (LVEF) and rs1136201 genotype was seen in the trastuzumab-treated or non–trastuzumab-treated patients. Moreover, mean LVEF and cardiac event rates were similar in all rs7853758 genotype groups treated with anthracycline-based therapy. Conclusions: In the largest study to date to evaluate whether two polymorphisms are associated with DFS and/or cardiac toxicity in HER2-positive breast cancer treated with trastuzumab and/or anthracyclines, we observed no correlation.
Clinical and Kidney Structural Characteristics of Living Kidney Donors With Nephrolithiasis and Their Long-term Outcomes
D’Costa, Matthew R., Merzkani, Massini A., Denic, Aleksandar, Mullan, Aidan F., Larson, Joseph J., Kremers, Walter K., Park, Walter D., Alexander, Mariam P., Chakkera, Harini A., Taler, Sandra J., Erickson, Stephen B., Stegall, Mark D., Issa, Naim, Rule, Andrew D., Kremers, Walter K. , Đenić, Aleksandar , Chakkera, Harini A. , D’Costa, Matthew R. , Erickson, Stephen J, D'Costa, Matthew , Denic, Aleksandar , Chakkera, Harini A , Kremers, Walter K , Merzkani, Massini A., Mullan, Aidan F., Larson, Joseph J., Park, Walter D., Alexander, Mariam P., Taler, Sandra J., Erickson, Stephen B., Stegall, Mark D., Issa, Naim, Rule, Andrew D.

Mayo Clinic

Transplantation Direct | February 1, 2022 | Volume: 8 | Issue: 1 | Pages: e1278

10.1097/txd.0000000000001278 | PMID 34966845 Get It

Background. Nephrolithiasis in living kidney donors is concerning due to the potential impact on long-term postdonation kidney function. Methods. We performed a cohort study of living kidney donors from 2 centers with a baseline computed tomography scan and implantation renal biopsy. Donors (>5 y since donation) completed a follow-up survey or underwent chart review to assess eGFR and incident hypertension. Stone formers were classified as symptomatic if they had a past symptomatic episode or asymptomatic if only incidental radiographic kidney stones were identified during donor evaluation. We compared baseline clinical, imaging, and biopsy characteristics by stone former status including review of metabolic evaluations in stone formers. Long-term risks of renal complications (low eGFR and hypertension) by stone former status were evaluated. Results. There were 12 symptomatic and 76 asymptomatic stone formers among 866 donors. Overall, baseline clinical characteristics and implantation biopsy findings were similar between stone formers and non-stone formers. After a median follow-up of 10 y, stone former status was not associated with eGFR <60 mL/min/1.73 m2, eGFR <45 mL/min/1.73 m2, or hypertension. Conclusions. Both asymptomatic and symptomatic SF have favorable histology findings at baseline. Long-term kidney outcomes were favorable in select stone formers with no evident increased long-term risk for decreased kidney function or hypertension after donation.
Sex-specific lesion pattern of functional outcomes after stroke
Bretzner, Martin , Hong, Sung‐Min , Schirmer, Markus D. , Cohen, Alexander L. , Regenhardt, Robert W. , Donahue, Kathleen, Nardin, Marco, Etherton, Mark R. , Hancock, Brandon L., Mocking, Steven J. T. , McIntosh, Elissa C. , Benavente, Oscar, Donatti, Amanda , Heitsch, Laura , Jiménez-Conde, Jordi , Kittner, Steven J. , Levi, Christopher , Rolfs, Arndt , Schmidt, Reinhold , Sharma, Pankaj , Słowik, Agnieszka , Söderholm, Martin , Sousa, Alessandro , Stanne, Tara M. , Strbian, Daniel , Thijs, Vincent , Wassélius, Johan , Woo, Daniel , Zand, Ramin , McArdle, Patrick F. , Worrall, Bradford B. , Maguire, Jane , Fox, Michael , Bzdok, Danilo , Wu, Ona , Rost, Natalia S. , Bretzner, Martin , Cohen, Alexander , Etherton, Mark R , Jood, Katarina , Lemmens, Robin , Strbian, Daniel , Regenhardt, Robert W , Wu, Ona , Zand, Ramin , Bonkhoff, Anna K. , Dalca, Adrian Vasile , Giese, Anne‐Katrin , Attia, John , Bevan, Steve , Cole, John W. , Griessenauer, Christoph J. , Holmegaard, Lukas , Lemmens, Robin , McDonough, Caitrin W. , Meschia, James F. , Phuah, Chia‐Ling , Ropele, Stefan , Rosand, Jonathan M. , Roquer, Jaume , Rundek, Tatjana , Sacco, Ralph L. , Tatlisumak, Turgut , Vagal, Achala , Jern, Christina , Lindgren, Arne G.

Mayo Clinic

Brain Communications | January 31, 2022 | Volume: 4 | Issue: 2 | Pages: No page available

10.1093/braincomms/fcac020 | PMID 35282166 Get It

Abstract Stroke represents a considerable burden of disease for both men and women. However, a growing body of literature suggests clinically relevant sex differences in the underlying causes, presentations and outcomes of acute ischaemic stroke. In a recent study, we reported sex divergences in lesion topographies: specific to women, acute stroke severity was linked to lesions in the left-hemispheric posterior circulation. We here determined whether these sex-specific brain manifestations also affect long-term outcomes. We relied on 822 acute ischaemic patients [age: 64.7 (15.0) years, 39% women] originating from the multi-centre MRI-GENIE study to model unfavourable outcomes (modified Rankin Scale &gt;2) based on acute neuroimaging data in a Bayesian hierarchical framework. Lesions encompassing bilateral subcortical nuclei and left-lateralized regions in proximity to the insula explained outcomes across men and women (area under the curve = 0.81). A pattern of left-hemispheric posterior circulation brain regions, combining left hippocampus, precuneus, fusiform and lingual gyrus, occipital pole and latero-occipital cortex, showed a substantially higher relevance in explaining functional outcomes in women compared to men [mean difference of Bayesian posterior distributions (men – women) = −0.295 (90% highest posterior density interval = −0.556 to −0.068)]. Once validated in prospective studies, our findings may motivate a sex-specific approach to clinical stroke management and hold the promise of enhancing outcomes on a population level.
Using the Merlin assay for reducing sentinel lymph node biopsy complications in melanoma: a retrospective cohort study
Sadurní, Mariana B. , Quattrocchi, Enrica , Kobic, Ajdin, Sominidi‐Damodaran, Sindhuja , Dwarkasing, Jvalini, Meerstein‐Kessel, Lisette , Bridges, Alina G. , Meves, Alexander , Sominidi-Damodaran, Sindhuja, Hieken, Tina J.

Mayo Clinic

International Journal of Dermatology | January 31, 2022 | Volume: 61 | Issue: 7 | Pages: 848-854

10.1111/ijd.16056 | PMID 35100440 Get It

AbstractBackgroundThe assessment of the sentinel lymph node is a cornerstone of melanoma staging. However, ~80% of sentinel lymph node biopsies (SLNB) are negative and nontherapeutic, and patients are unnecessarily exposed to surgery‐related complications. Here, we gauged the potential of the Merlin assay to reduce SLNB‐associated complications. The Merlin assay uses clinicopathologic variables and tumor gene expression profiling to identify low‐risk patients who may forgo SLNB.MethodsWe utilized the Merlin test development cohort to determine SLNB complication rates for procedures performed between 2004 and 2018 at Mayo Clinic. Complications evaluated were lymphedema, seroma, infection/cellulitis, hematoma, and wound dehiscence. Patients who underwent a completion lymph node dissection were excluded.ResultsA total of 558 patients were included. The overall 90‐day complication rate specific to SLNB (1 year for lymphedema) was 17.4%. The most common complications were seroma (9.3%), infection/cellulitis (4.8%), and lymphedema (4.3%). All three were more common in patients with a lower extremity primary tumor location versus other locations. With Merlin test results applied, SLNB‐related complications would have decreased by 59%.ConclusionSLNB is a safe procedure but carries a significant complication rate. Merlin testing might reduce the need for SLNB and its associated complications.